Global Cancer Biopsy Market 2021 by Company, Regions, Type and Application, Forecast to 2026
Page: 122
Published Date: 28 Jan 2021
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The Cancer Biopsy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cancer Biopsy size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Cancer Biopsy market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cancer Biopsy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tissue Biopsies
Liquid Biopsies
Others
Market segment by Application, can be divided into
Breast Cancer
Colorectal Cancer
Cervical Cancers
Lung Cancers
Prostate Cancers
Skin Cancers
Blood Cancers
Kidney Cancers
Others
Market segment by players, this report covers
Qiagen N.V.
Illumina, Inc.
ANGLE Plc
Myriad Genetics
Hologic, Inc.
Biocept, Inc.
Thermo Fisher Scientific, Inc.
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL, Inc.
Guardant Health
Exact Sciences Corporation
Freenome Holdings, Inc.
Oncimmune
Chronix Biomedical, Inc.
Personal Genome Diagnostics Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Cancer Biopsy
1.2 Classification of Cancer Biopsy by Type
1.2.1 Overview: Global Cancer Biopsy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cancer Biopsy Revenue Market Share by Type in 2020
1.2.3 Tissue Biopsies
1.2.4 Liquid Biopsies
1.2.5 Others
1.3 Global Cancer Biopsy Market by Application
1.3.1 Overview: Global Cancer Biopsy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Breast Cancer
1.3.3 Colorectal Cancer
1.3.4 Cervical Cancers
1.3.5 Lung Cancers
1.3.6 Prostate Cancers
1.3.7 Skin Cancers
1.3.8 Blood Cancers
1.3.9 Kidney Cancers
1.3.10 Others
1.4 Global Cancer Biopsy Market Size & Forecast
1.5 Global Cancer Biopsy Market Size and Forecast by Region
1.5.1 Global Cancer Biopsy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cancer Biopsy Market Size by Region, (2016-2021)
1.5.3 North America Cancer Biopsy Market Size and Prospect (2016-2026)
1.5.4 Europe Cancer Biopsy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cancer Biopsy Market Size and Prospect (2016-2026)
1.5.6 South America Cancer Biopsy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cancer Biopsy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cancer Biopsy Market Drivers
1.6.2 Cancer Biopsy Market Restraints
1.6.3 Cancer Biopsy Trends Analysis
2.1 Qiagen N.V.
2.1.1 Qiagen N.V. Details
2.1.2 Qiagen N.V. Major Business
2.1.3 Qiagen N.V. Cancer Biopsy Product and Solutions
2.1.4 Qiagen N.V. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Qiagen N.V. Recent Developments and Future Plans
2.2 Illumina, Inc.
2.2.1 Illumina, Inc. Details
2.2.2 Illumina, Inc. Major Business
2.2.3 Illumina, Inc. Cancer Biopsy Product and Solutions
2.2.4 Illumina, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Illumina, Inc. Recent Developments and Future Plans
2.3 ANGLE Plc
2.3.1 ANGLE Plc Details
2.3.2 ANGLE Plc Major Business
2.3.3 ANGLE Plc Cancer Biopsy Product and Solutions
2.3.4 ANGLE Plc Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ANGLE Plc Recent Developments and Future Plans
2.4 Myriad Genetics
2.4.1 Myriad Genetics Details
2.4.2 Myriad Genetics Major Business
2.4.3 Myriad Genetics Cancer Biopsy Product and Solutions
2.4.4 Myriad Genetics Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Myriad Genetics Recent Developments and Future Plans
2.5 Hologic, Inc.
2.5.1 Hologic, Inc. Details
2.5.2 Hologic, Inc. Major Business
2.5.3 Hologic, Inc. Cancer Biopsy Product and Solutions
2.5.4 Hologic, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Hologic, Inc. Recent Developments and Future Plans
2.6 Biocept, Inc.
2.6.1 Biocept, Inc. Details
2.6.2 Biocept, Inc. Major Business
2.6.3 Biocept, Inc. Cancer Biopsy Product and Solutions
2.6.4 Biocept, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Biocept, Inc. Recent Developments and Future Plans
2.7 Thermo Fisher Scientific, Inc.
2.7.1 Thermo Fisher Scientific, Inc. Details
2.7.2 Thermo Fisher Scientific, Inc. Major Business
2.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Product and Solutions
2.7.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business
2.8.3 Danaher Cancer Biopsy Product and Solutions
2.8.4 Danaher Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Danaher Recent Developments and Future Plans
2.9 Lucence Diagnostics Pte. Ltd.
2.9.1 Lucence Diagnostics Pte. Ltd. Details
2.9.2 Lucence Diagnostics Pte. Ltd. Major Business
2.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product and Solutions
2.9.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Lucence Diagnostics Pte. Ltd. Recent Developments and Future Plans
2.10 GRAIL, Inc.
2.10.1 GRAIL, Inc. Details
2.10.2 GRAIL, Inc. Major Business
2.10.3 GRAIL, Inc. Cancer Biopsy Product and Solutions
2.10.4 GRAIL, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 GRAIL, Inc. Recent Developments and Future Plans
2.11 Guardant Health
2.11.1 Guardant Health Details
2.11.2 Guardant Health Major Business
2.11.3 Guardant Health Cancer Biopsy Product and Solutions
2.11.4 Guardant Health Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Guardant Health Recent Developments and Future Plans
2.12 Exact Sciences Corporation
2.12.1 Exact Sciences Corporation Details
2.12.2 Exact Sciences Corporation Major Business
2.12.3 Exact Sciences Corporation Cancer Biopsy Product and Solutions
2.12.4 Exact Sciences Corporation Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Exact Sciences Corporation Recent Developments and Future Plans
2.13 Freenome Holdings, Inc.
2.13.1 Freenome Holdings, Inc. Details
2.13.2 Freenome Holdings, Inc. Major Business
2.13.3 Freenome Holdings, Inc. Cancer Biopsy Product and Solutions
2.13.4 Freenome Holdings, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Freenome Holdings, Inc. Recent Developments and Future Plans
2.14 Oncimmune
2.14.1 Oncimmune Details
2.14.2 Oncimmune Major Business
2.14.3 Oncimmune Cancer Biopsy Product and Solutions
2.14.4 Oncimmune Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Oncimmune Recent Developments and Future Plans
2.15 Chronix Biomedical, Inc.
2.15.1 Chronix Biomedical, Inc. Details
2.15.2 Chronix Biomedical, Inc. Major Business
2.15.3 Chronix Biomedical, Inc. Cancer Biopsy Product and Solutions
2.15.4 Chronix Biomedical, Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Chronix Biomedical, Inc. Recent Developments and Future Plans
2.16 Personal Genome Diagnostics Inc.
2.16.1 Personal Genome Diagnostics Inc. Details
2.16.2 Personal Genome Diagnostics Inc. Major Business
2.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Product and Solutions
2.16.4 Personal Genome Diagnostics Inc. Cancer Biopsy Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Personal Genome Diagnostics Inc. Recent Developments and Future Plans
3.1 Global Cancer Biopsy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Cancer Biopsy Players Market Share
3.2.2 Top 10 Cancer Biopsy Players Market Share
3.2.3 Market Competition Trend
3.3 Cancer Biopsy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4.1 Global Cancer Biopsy Revenue and Market Share by Type (2016-2021)
4.2 Global Cancer Biopsy Market Forecast by Type (2021-2026)
5.1 Global Cancer Biopsy Revenue Market Share by Application (2016-2021)
5.2 Cancer Biopsy Market Forecast by Application (2021-2026)
6.1 North America Cancer Biopsy Revenue by Type (2016-2026)
6.2 North America Cancer Biopsy Revenue by Application (2016-2026)
6.3 North America Cancer Biopsy Market Size by Country
6.3.1 North America Cancer Biopsy Revenue by Country (2016-2026)
6.3.2 United States Cancer Biopsy Market Size and Forecast (2016-2026)
6.3.3 Canada Cancer Biopsy Market Size and Forecast (2016-2026)
6.3.4 Mexico Cancer Biopsy Market Size and Forecast (2016-2026)
7.1 Europe Cancer Biopsy Revenue by Type (2016-2026)
7.2 Europe Cancer Biopsy Revenue by Application (2016-2026)
7.3 Europe Cancer Biopsy Market Size by Country
7.3.1 Europe Cancer Biopsy Revenue by Country (2016-2026)
7.3.2 Germany Cancer Biopsy Market Size and Forecast (2016-2026)
7.3.3 France Cancer Biopsy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cancer Biopsy Market Size and Forecast (2016-2026)
7.3.5 Russia Cancer Biopsy Market Size and Forecast (2016-2026)
7.3.6 Italy Cancer Biopsy Market Size and Forecast (2016-2026)
8.1 Asia-Pacific Cancer Biopsy Revenue by Type (2016-2026)
8.2 Asia-Pacific Cancer Biopsy Revenue by Application (2016-2026)
8.3 Asia-Pacific Cancer Biopsy Market Size by Region
8.3.1 Asia-Pacific Cancer Biopsy Revenue by Region (2016-2026)
8.3.2 China Cancer Biopsy Market Size and Forecast (2016-2026)
8.3.3 Japan Cancer Biopsy Market Size and Forecast (2016-2026)
8.3.4 South Korea Cancer Biopsy Market Size and Forecast (2016-2026)
8.3.5 India Cancer Biopsy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cancer Biopsy Market Size and Forecast (2016-2026)
8.3.7 Australia Cancer Biopsy Market Size and Forecast (2016-2026)
9.1 South America Cancer Biopsy Revenue by Type (2016-2026)
9.2 South America Cancer Biopsy Revenue by Application (2016-2026)
9.3 South America Cancer Biopsy Market Size by Country
9.3.1 South America Cancer Biopsy Revenue by Country (2016-2026)
9.3.2 Brazil Cancer Biopsy Market Size and Forecast (2016-2026)
9.3.3 Argentina Cancer Biopsy Market Size and Forecast (2016-2026)
10.1 Middle East & Africa Cancer Biopsy Revenue by Type (2016-2026)
10.2 Middle East & Africa Cancer Biopsy Revenue by Application (2016-2026)
10.3 Middle East & Africa Cancer Biopsy Market Size by Country
10.3.1 Middle East & Africa Cancer Biopsy Revenue by Country (2016-2026)
10.3.2 Turkey Cancer Biopsy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cancer Biopsy Market Size and Forecast (2016-2026)
10.3.4 UAE Cancer Biopsy Market Size and Forecast (2016-2026)
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Cancer Biopsy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cancer Biopsy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cancer Biopsy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cancer Biopsy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cancer Biopsy Revenue Market Share by Region (2021-2026)
Table 6. Qiagen N.V. Corporate Information, Head Office, and Major Competitors
Table 7. Qiagen N.V. Major Business
Table 8. Qiagen N.V. Cancer Biopsy Product and Solutions
Table 9. Qiagen N.V. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Illumina, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Illumina, Inc. Major Business
Table 12. Illumina, Inc. Cancer Biopsy Product and Solutions
Table 13. Illumina, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. ANGLE Plc Corporate Information, Head Office, and Major Competitors
Table 15. ANGLE Plc Major Business
Table 16. ANGLE Plc Cancer Biopsy Product and Solutions
Table 17. ANGLE Plc Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 19. Myriad Genetics Major Business
Table 20. Myriad Genetics Cancer Biopsy Product and Solutions
Table 21. Myriad Genetics Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Hologic, Inc. Corporate Information, Head Office, and Major Competitors
Table 23. Hologic, Inc. Major Business
Table 24. Hologic, Inc. Cancer Biopsy Product and Solutions
Table 25. Hologic, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Biocept, Inc. Corporate Information, Head Office, and Major Competitors
Table 27. Biocept, Inc. Major Business
Table 28. Biocept, Inc. Cancer Biopsy Product and Solutions
Table 29. Biocept, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors
Table 31. Thermo Fisher Scientific, Inc. Major Business
Table 32. Thermo Fisher Scientific, Inc. Cancer Biopsy Product and Solutions
Table 33. Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Danaher Corporate Information, Head Office, and Major Competitors
Table 35. Danaher Major Business
Table 36. Danaher Cancer Biopsy Product and Solutions
Table 37. Danaher Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Lucence Diagnostics Pte. Ltd. Corporate Information, Head Office, and Major Competitors
Table 39. Lucence Diagnostics Pte. Ltd. Major Business
Table 40. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product and Solutions
Table 41. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. GRAIL, Inc. Corporate Information, Head Office, and Major Competitors
Table 43. GRAIL, Inc. Major Business
Table 44. GRAIL, Inc. Cancer Biopsy Product and Solutions
Table 45. GRAIL, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Guardant Health Corporate Information, Head Office, and Major Competitors
Table 47. Guardant Health Major Business
Table 48. Guardant Health Cancer Biopsy Product and Solutions
Table 49. Guardant Health Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Exact Sciences Corporation Corporate Information, Head Office, and Major Competitors
Table 51. Exact Sciences Corporation Major Business
Table 52. Exact Sciences Corporation Cancer Biopsy Product and Solutions
Table 53. Exact Sciences Corporation Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Freenome Holdings, Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Freenome Holdings, Inc. Major Business
Table 56. Freenome Holdings, Inc. Cancer Biopsy Product and Solutions
Table 57. Freenome Holdings, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Oncimmune Corporate Information, Head Office, and Major Competitors
Table 59. Oncimmune Major Business
Table 60. Oncimmune Cancer Biopsy Product and Solutions
Table 61. Oncimmune Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Chronix Biomedical, Inc. Corporate Information, Head Office, and Major Competitors
Table 63. Chronix Biomedical, Inc. Major Business
Table 64. Chronix Biomedical, Inc. Cancer Biopsy Product and Solutions
Table 65. Chronix Biomedical, Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Personal Genome Diagnostics Inc. Corporate Information, Head Office, and Major Competitors
Table 67. Personal Genome Diagnostics Inc. Major Business
Table 68. Personal Genome Diagnostics Inc. Cancer Biopsy Product and Solutions
Table 69. Personal Genome Diagnostics Inc. Cancer Biopsy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Global Cancer Biopsy Revenue (USD Million) by Players (2019-2021)
Table 71. Global Cancer Biopsy Revenue Share by Players (2019-2021)
Table 72. Breakdown of Cancer Biopsy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 73. Cancer Biopsy Players Head Office, Products and Services Provided
Table 74. Cancer Biopsy Mergers & Acquisitions in the Past Five Years
Table 75. Cancer Biopsy New Entrants and Expansion Plans
Table 76. Global Cancer Biopsy Revenue (USD Million) by Type (2016-2021)
Table 77. Global Cancer Biopsy Revenue Share by Type (2016-2021)
Table 78. Global Cancer Biopsy Revenue Forecast by Type (2021-2026)
Table 79. Global Cancer Biopsy Revenue by Application (2016-2021)
Table 80. Global Cancer Biopsy Revenue Forecast by Application (2021-2026)
Table 81. North America Cancer Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 82. North America Cancer Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 83. North America Cancer Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 84. North America Cancer Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 85. North America Cancer Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 86. North America Cancer Biopsy Revenue by Country (2021-2026) & (USD Million)
Table 87. Europe Cancer Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 88. Europe Cancer Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 89. Europe Cancer Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 90. Europe Cancer Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 91. Europe Cancer Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 92. Europe Cancer Biopsy Revenue by Country (2021-2026) & (USD Million)
Table 93. Asia-Pacific Cancer Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 94. Asia-Pacific Cancer Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 95. Asia-Pacific Cancer Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 96. Asia-Pacific Cancer Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 97. Asia-Pacific Cancer Biopsy Revenue by Region (2016-2021) & (USD Million)
Table 98. Asia-Pacific Cancer Biopsy Revenue by Region (2021-2026) & (USD Million)
Table 99. South America Cancer Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 100. South America Cancer Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 101. South America Cancer Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 102. South America Cancer Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 103. South America Cancer Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 104. South America Cancer Biopsy Revenue by Country (2021-2026) & (USD Million)
Table 105. Middle East & Africa Cancer Biopsy Revenue by Type (2016-2021) & (USD Million)
Table 106. Middle East & Africa Cancer Biopsy Revenue by Type (2021-2026) & (USD Million)
Table 107. Middle East & Africa Cancer Biopsy Revenue by Application (2016-2021) & (USD Million)
Table 108. Middle East & Africa Cancer Biopsy Revenue by Application (2021-2026) & (USD Million)
Table 109. Middle East & Africa Cancer Biopsy Revenue by Country (2016-2021) & (USD Million)
Table 110. Middle East & Africa Cancer Biopsy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cancer Biopsy Picture
Figure 2. Global Cancer Biopsy Revenue Market Share by Type in 2020
Figure 3. Tissue Biopsies
Figure 4. Liquid Biopsies
Figure 5. Others
Figure 6. Cancer Biopsy Revenue Market Share by Application in 2020
Figure 7. Breast Cancer Picture
Figure 8. Colorectal Cancer Picture
Figure 9. Cervical Cancers Picture
Figure 10. Lung Cancers Picture
Figure 11. Prostate Cancers Picture
Figure 12. Skin Cancers Picture
Figure 13. Blood Cancers Picture
Figure 14. Kidney Cancers Picture
Figure 15. Others Picture
Figure 16. Global Cancer Biopsy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 17. Global Cancer Biopsy Revenue and Forecast (2016-2026) & (USD Million)
Figure 18. Global Cancer Biopsy Revenue Market Share by Region (2016-2026)
Figure 19. Global Cancer Biopsy Revenue Market Share by Region in 2020
Figure 20. North America Cancer Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Europe Cancer Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Asia-Pacific Cancer Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 23. South America Cancer Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 24. Middle East and Africa Cancer Biopsy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 25. Cancer Biopsy Market Drivers
Figure 26. Cancer Biopsy Market Restraints
Figure 27. Cancer Biopsy Market Trends
Figure 28. Qiagen N.V. Recent Developments and Future Plans
Figure 29. Illumina, Inc. Recent Developments and Future Plans
Figure 30. ANGLE Plc Recent Developments and Future Plans
Figure 31. Myriad Genetics Recent Developments and Future Plans
Figure 32. Hologic, Inc. Recent Developments and Future Plans
Figure 33. Biocept, Inc. Recent Developments and Future Plans
Figure 34. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Figure 35. Danaher Recent Developments and Future Plans
Figure 36. Lucence Diagnostics Pte. Ltd. Recent Developments and Future Plans
Figure 37. GRAIL, Inc. Recent Developments and Future Plans
Figure 38. Guardant Health Recent Developments and Future Plans
Figure 39. Exact Sciences Corporation Recent Developments and Future Plans
Figure 40. Freenome Holdings, Inc. Recent Developments and Future Plans
Figure 41. Oncimmune Recent Developments and Future Plans
Figure 42. Chronix Biomedical, Inc. Recent Developments and Future Plans
Figure 43. Personal Genome Diagnostics Inc. Recent Developments and Future Plans
Figure 44. Global Cancer Biopsy Revenue Share by Players in 2020
Figure 45. Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 46. Global Top 3 Players Cancer Biopsy Revenue Market Share in 2020
Figure 47. Global Top 10 Players Cancer Biopsy Revenue Market Share in 2020
Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 49. Global Cancer Biopsy Revenue Share by Type in 2020
Figure 50. Global Cancer Biopsy Market Share Forecast by Type (2021-2026)
Figure 51. Global Cancer Biopsy Revenue Share by Application in 2020
Figure 52. Global Cancer Biopsy Market Share Forecast by Application (2021-2026)
Figure 53. North America Cancer Biopsy Sales Market Share by Type (2016-2026)
Figure 54. North America Cancer Biopsy Sales Market Share by Application (2016-2026)
Figure 55. North America Cancer Biopsy Revenue Market Share by Country (2016-2026)
Figure 56. United States Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Canada Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Mexico Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Europe Cancer Biopsy Sales Market Share by Type (2016-2026)
Figure 60. Europe Cancer Biopsy Sales Market Share by Application (2016-2026)
Figure 61. Europe Cancer Biopsy Revenue Market Share by Country (2016-2026)
Figure 62. Germany Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. France Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. United Kingdom Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Russia Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Italy Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Asia-Pacific Cancer Biopsy Sales Market Share by Type (2016-2026)
Figure 68. Asia-Pacific Cancer Biopsy Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Cancer Biopsy Revenue Market Share by Region (2016-2026)
Figure 70. China Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Japan Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South Korea Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. India Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Southeast Asia Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Australia Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South America Cancer Biopsy Sales Market Share by Type (2016-2026)
Figure 77. South America Cancer Biopsy Sales Market Share by Application (2016-2026)
Figure 78. South America Cancer Biopsy Revenue Market Share by Country (2016-2026)
Figure 79. Brazil Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Argentina Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Middle East and Africa Cancer Biopsy Sales Market Share by Type (2016-2026)
Figure 82. Middle East and Africa Cancer Biopsy Sales Market Share by Application (2016-2026)
Figure 83. Middle East and Africa Cancer Biopsy Revenue Market Share by Country (2016-2026)
Figure 84. Turkey Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Saudi Arabia Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. UAE Cancer Biopsy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Methodology
Figure 88. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Qiagen N.V. Illumina, Inc. ANGLE Plc Myriad Genetics Hologic, Inc. Biocept, Inc. Thermo Fisher Scientific, Inc. Danaher Lucence Diagnostics Pte. Ltd. GRAIL, Inc. Guardant Health Exact Sciences Corporation Freenome Holdings, Inc. Oncimmune Chronix Biomedical, Inc. Personal Genome Diagnostics Inc.
Related Reports
14 Jan 2022
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
